Federal Circuit Upholds Patent Ruling In Diprivan Case
The Federal Circuit Court of Appeals has upheld a lower court's ruling that Mayne Pharma infringed on AstraZeneca's patents for its anesthetic and sedative Diprivan, although the lower court did err...To view the full article, register now.
Already a subscriber? Click here to view full article